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Article abstract-We evaluated the consistency of the diagnosis of dementia in a multicultural, longitudinal com- 
munity-based study of cognitive impairment and dementia. We diagnosed dementia using a fixed neuropsychological 
paradigm; the diagnosis also required historical evidence of functional impairment. In a sample of 656 subjects with 
at  least one annual follow-up examination, dementia was confirmed at  1 year in 89% of the 304 subjects initially de- 
mented, and in 90% of the 136 subjects with the initial diagnosis of probable Alzheimer’s disease (AD). The 34 ini- 
tially demented subjects who failed to meet criteria for dementia a t  follow-up included 13 with an initial diagnosis of 
probable AD. All 34 still had evidence of cognitive impairment; this group was more likely to have a history of pul- 
monary disease, multiple medication use, or chronic alcohol use than other demented patients. Consistency of demen- 
tia diagnosis did not vary according to educational attainment or ethnic background. The use of a neuropsychological 
paradigm such as ours in large longitudinal studies of dementia may minimize interobserver diagnostic variability or 
diagnostic drift over time while contributing the benefits of a comprehensive cognitive evaluation to the diagnostic 
process. 
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Community-based epidemiologic studies have not 
addressed the consistency of the diagnosis of de- 
mentia, and specifically of Alzheimer’s disease 
(AD), over time. We analyzed data from a longitu- 
dinal study of aging and dementia in North Man- 
hattan to look at this issue. We evaluated whether 
variation in cultural backgrounds and educational 
experience in our community influenced the consis- 
tency of our diagnoses. Of particular interest were 
initially demented subjects who failed to  meet de- 
mentia criteria at follow-up. We sought to identify 
factors to account for this diagnostic change. 
Methods. Setting and subjects. Data were obtained from 
a total of 1,764 subjects who were part of a registry for 
degenerative disease in the elderly residing in the Wash- 
ington Heights and Inwood communities of New York 
City during the period of April 1, 1988, to December 31, 
1990. Briefly, the registry used information from all 
available medical sources-regional hospitals (including 
inpatient and outpatient services), private practitioners 
in the community, federal and state health agencies, 
health maintenance organizations, and senior centers- 
to identify individuals with possible cognitive impair- 
ment, who then underwent a cognitive screening evalua- 
tion. A proportion of those subjects screened underwent a 
subsequent comprehensive evaluation, described below. 
Each reporting site also identified healthy elderly who 
also took the screening examination and served as con- 
trols in some investigations. The refusal rate for both 
cases and controls was less than 20% using this method. 
Data collection. Information regarding current age, 
date of birth, location of birth, residence since birth, oc- 
cupation, and duration of formal education was obtained 
in the initial interview or record review. For ethnic group 
assignment, a modification of the United States Census 
Bureau’ format was used. Subjects who identified them- 
selves as Hispanic were classified as such. Non-Hispan- 
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ics were further classified as white, black, or other. 
Medical evaluation. This was done as part of the com- 
prehensive evaluation, usually in the subject’s home. 
Past and current medical history and medications were 
documented in a semistructured format. History of 
chronic alcohol consumption was recorded categorically, 
ie, yesfno, without quantification or the use of specific 
probes. If the subject was unable to provide history or ap- 
peared to be demented, information was obtained from 
available relatives or, in some cases, from a home health 
aide. Performance of activities of daily living was rated 
using part 1 of the Blessed Dementia Rating Scale2 and 
the Schwab and England rating scale of activities of daily 
l i ~ i n g . ~  Interviews were conducted either in Spanish or 
English, according to the subject’s wishes. Neurologic 
and brief general physical examinations were performed 
on all subjects. 
Neuropsychological evaluation. Comprehensive evalu- 
ation included a neuropsychological assessment4 com- 
prising tests of orientation, verbal and nonverbal mem- 
ory, attention, construction, language, and abstract rea- 
soning. A fured paradigm was used to determine if a sub- 
ject had sufficient cognitive deficit to meet criteria for de- 
mentia.4 
Diagnostic conference. At a consensus conference, all 
the information derived from the neurologic and neu- 
ropsychological assessments, together with any available 
ancillary information (eg, CT results, laboratory or 
pathology results), was reviewed by a group of physicians 
and neuropsychologists, some of whom were directly in- 
volved in the assessment of the patient. A modified Clini- 
cal Dementia Rating (CDR) score5 was assigned to reflect 
severity of dementia, taking account of all available in- 
formation. 
Evaluations were repeated annually. After each visit, 
data were collected and forwarded to the consensus confer- 
ence for review. For follow-ups, information available from 
the previous visit was reviewed after a provisional consen- 
sus diagnosis was achieved. Any previously collected infor- 
mation such as CT results or history of stroke or psychi- 
atric illness was considered in formulating the definitive 
consensus diagnosis, the basis for these analyses. 
Specific diagnostic criteria. Dementia. Diagnostic cri- 
teria for dementia were slightly modified from DSM III- 
R.6 A fixed paradigm was used to establish the presence 
of intellectual dysfunction based on neuropsychological 
test performance, which was compared with a series of 
cutoff scores developed in a pilot study in the commu- 
 nit^.^ No adjustments were made in either cutoffs or sub- 
ject scores according to  educational attainment. Using 
this paradigm, we diagnosed dementia if the subject 
scored below cutoffs in at least two of three memory tests 
and below cutoffs in a t  least two other cognitive areas, 
including abstract thinking, constructional ability, lan- 
guage, and orientation, and had evidence of impaired ac- 
tivities of daily living or social or occupational function. 
Dementia was not diagnosed if delirium or altered con- 
sciousness was present, and may alone have accounted 
for the cognitive impairment. 
Alzheimer’s d i s e w  Operational criteria for this diag- 
nosis were modeled after those recommended by the 
NINCDS-ADRDA Work Group’ for possible and probable 
AD. We also applied the diagnosis of probable or possible 
AD with concomitant stroke to patients with stroke if the 
dementia syndrome began more than 3 months after 
stroke or if behavioral deficits due to stroke were super- 
imposed on a preexisting dementing syndrome. When 
judged by the neuropathologic findings at  autopsy, the 
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Table 1. Patient characteristics according to 
cognitive function at initial evaluation 
No cognitive Cognitive 
impairment impairment Demented Total 
(n = 123) (n = 229) (n = 304) (n = 656) 
Age (yr)* 72.8 (6.7) 77.0 (7.5) 81.7 (7.8) 78.4 (8.3) 
Gender(%F) 78 76 73 75 
Ethnicity 
%White 15 14 15 15 
% Black 28 31 42 35 
%Hispanic 57 55 43 50 
(yr)* 
Education 9.3 (4.2) 7.0 (4.2) 6.8 (4.2) 7.4 (4.3) 
* Mean, with standard deviation in parentheses. I 
accuracy of a clinical diagnosis of AD in subjects partici- 
pating in the registry exceeds 90%. 
Cerebrovascular d ement ia, The diagnosis of “demen- 
tia related to focal effects of stroke” was made when 
stroke appeared to be the only cause for dementia. 
oenitive impairment, This diagnosis was applied to 
subjects who did not meet criteria for dementia but who 
had more than one neuropsychological test score below 
previously determined cutoffs, and to subjects who satis- 
fied neuropsychological criteria for dementia but who 
lacked evidence of functional impairment. 
Data analysis. To facilitate analyses, subjects were 
separated into four groups. “Nondemented” (NoDem) sub- 
jects were not demented at  either initial or follow-up eval- 
uations. “Incident dementia” (IDem) subjects were not de- 
mented initially, but were demented at  follow-up 1 year 
later. “Stable dementia’’ (SDem) subjects were demented 
a t  both evaluations, and “unstable dementia’’ (UDem) 
subjects were demented initially but not a t  follow-up. 
Three different analytic approaches were taken. First, be- 
tween-group comparisons of demographic and medical 
variables, and the frequencies of specific causes for de- 
mentia, were made using one-way ANOVA8 or chi-square 
tests.g Second, record review of subjects with UDem was 
undertaken seeking any obvious reason for the cognitive 
improvement between evaluations. Finally, logistic re- 
gression analyses1° with dementia group (SDem or 
UDem) as the outcome variable were performed to evalu- 
ate whether specific demographic or medical factors were 
associated with diagnostic inconsistency. 
. .  
Results. Of the 1,764 subjects screened, compre- 
hensive evaluation was performed on a sample of 
1,058 composed of both screen-positive and screen- 
negative subjects. We report here on the 656 sub- 
jects who had at least one subsequent annual fol- 
low-up evaluation. The 402 without follow-up, ex- 
cluded from this analysis, included 22% who died 
before the next follow-up, 29% with evaluations 
pending, 20% who had moved or could not be lo- 
cated, 18% who were ill or were temporarily un- 
available, and 11% who refused follow-up. 
Subjects included 493 women and 163 men. At 
baseline, 304 were demented, 229 were cognitively 
impaired, and 123 had no cognitive impairment 
(table 1). Cognitively normal subjects were younger 
and had more years of education than did the other 
Table 3. Etiology of dementia at initial evaluation Table 2. Patient characteristics at initial 
evaluation according to dementia category based 
on initial and follow-up evaluations 
Age (yr)8 
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History of 55 57 84 56 
* Subjects first diagnosed demented a t  follow-up. 
t Subjects diagnosed demented at  initial evaluation, but not a t  fol- 
low-up. 
$ Subjects diagnosed demented a t  both evaluations. 
8 Mean, with standard deviation in parentheses. 
¶ Total recall of the Buschke Selective Reminding Test. 
two categories (Tukey honestly significant differ- 
ence [HSDI, ~0 .05 ) .  Cognitively impaired subjects 
were younger than those with dementia (Tukey 
HSD, ~0 .05 ) .  At 1-year follow-up, there were 63 in- 
cident cases of dementia, of whom four had previ- 
ously been cognitively normal and 59 were previ- 
ously considered cognitively impaired. In 34 of the 
304 subjects demented a t  initial evaluation, de- 
mentia was not confirmed at 1-year follow-up be- 
cause in every case the neuropsychological criteria 
for dementia were no longer met. Although not de- 
mented at  follow-up, all 34 subjects still had evi- 
dence of some cognitive impairment. Of the 304 ini- 
tially demented, 238 had a diagnosis of AD (ie, pos- 
sible AD or probable AD). At follow-up, 215 of these 
had diagnoses of AD, one had a diagnosis of “de- 
mentia cause unknown,” and 23 no longer met cri- 
teria for dementia. When only cases with an initial 
diagnosis of probable AD were considered (n = 136), 
follow-up diagnoses included probable AD in 111, 
possible AD in 12, and 13 no longer met criteria for 
dementia. 
The 656 subjects comprised 289 NoDem, 63 
IDem, 34 UDem, and 270 SDem subjects. Table 2 
lists subject characteristics within these categories. 
NoDem subjects were significantly younger than 
subjects in the other three groups, and SDem sub- 
jects were in addition older than IDem and UDem 
subjects (Tukey HSD, ~0 .05 ) .  NoDem subjects had 
more years of education than did the remaining 
three groups (Tukey HSD, ~0 .05 ) .  UDem subjects 
were more likely to have a history of hypertension 
Stable Unstable 
dementia* dementia? 
(n = 270) (n = 34) 
Probable AD 46% (123) 38% (13) 
Possible AD 34% (92) 29% (10) 
Vascular-related 7% (20) 6% (2) 
dementia 
Secondary dementia 1% (2) 3% (1) 
Other dementia 6% (17) 17% (6) 
Dementia cause 6% (16) 6% (2) 
unknown 
* Demented at both initial and follow-up evaluations. 
t Demented a t  initial evaluation only. 
AD Alzheimer’s disease. 
(chi-square Pearson, 0.013) and took more medica- 
tions (Tukey HSD, ~ 0 . 0 5 )  than did subjects from 
the other diagnostic categories. UDem subjects 
took on average the same number of medications at 
both evaluations. When compared with IDem and 
SDem subjects, UDem subjects were more likely to 
have a history of chronic pulmonary disease (chi- 
square, 0.02) and chronic alcohol use (chi-square, 
0.02). Within the population as a whole, the single 
memory item that correlated most strongly with 
CDR was the total recall of the Buschke Selective 
Reminding Test.” The mean performance on this 
test at initial evaluation was significantly different 
for all four groups (Tukey HSD, ~0.05) .  
Etiology of the dementia in the UDem and SDem 
groups at initial evaluation is outlined in table 3. A 
greater proportion of UDem subjects than of SDem 
subjects had diagnoses other than AD, although 
this was not a statistically significant difference. 
Chart review of UDem subjects was undertaken 
seeking additional history that might explain why 
cognitive improvement occurred between succes- 
sive evaluations. In three subjects, stroke symp- 
toms occurred within 5 months before the first 
evaluation. In four other subjects, a direct plausible 
explanation for the improvement was readily sug- 
gested. These four cases are outlined below. 
Patient 1. A 65-year-old woman with chronic 
lung disease recently complicated by bilateral 
pneumothorax that required 24-hour oxygen was 
initially evaluated as demented, with a CDR score 
of 1. One year later she performed somewhat bet- 
ter, and was rated CDR 0.5. 
Patient 2. A 91-year-old woman was diagnosed 
with probable AD (PAD), with a CDR score of 2. 
She had recently been admitted to the hospital 
after a rapid decline, and CT had excluded stroke. 
When seen 1 year later, she was much improved, 
with a CDR of 0. 
Patient 3. A 74-year-old man initially diagnosed 
with PAD and a CDR of 1 had a CDR of 0 the fol- 
lowing year. Subsequently, a history of “drinking 
alcohol all the time” was obtained. 
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Patient 4. An 81-year-old woman with diabetes, 
hypertension, and peripheral vascular disease with 
possible right-sided facial weakness was diagnosed 
as demented, with a CDR of 1. One year later, her 
CDR was 0, and the same examiner this time noted 
no equivocal lateralized neurologic signs. 
In retrospect, lung disease with hypoxemiahy- 
percapnia, a resolving confusional state, alcohol-re- 
lated cognitive problems (possibly intoxication), 
and stroke may have accounted for the poorer per- 
formance on testing at the first evaluations. While 
no longer meeting criteria for dementia at follow- 
up evaluation, all four subjects continued to show 
evidence of cognitive impairment. 
Concomitant medical conditions and medications 
were evaluated as factors that might contribute to 
the stability of dementia diagnosis. A logistic model 
was created in which the dichotomous outcome 
variable was a dementia group, either SDem or 
UDem. Potential confounders or contributing fac- 
tors evaluated as independent variables included 
the following: medications taken at initial evalua- 
tion; a history of chronic medical conditions includ- 
ing congestive heart failure, chronic renal disease, 
chronic pulmonary disease, chronic liver disease, 
thyroid disease, hypertension, and diabetes; a his- 
tory of chronic alcohol consumption; or head injury 
with loss of consciousness. Ethnicity, age, and edu- 
cation as a dichotomous variable (less than 8 or 8 
or more years of school) were evaluated in all logis- 
tic models. Three different categories of medica- 
tions were created for inclusion in  the logistic 
model. The first category comprised the number of 
the medications listed, from which a dichotomous 
variable (less than three or three or more medica- 
tions) was created. A second category consisted of 
the number of medications recognized to more com- 
monly be associated with cognitive impairment, 
and a dichotomous variable (one or less or two or 
more medications1 was created. Finally, a category 
of antihypertensives was created. Only one medica- 
tion category was evaluated in the logistic model at 
any time. In order to control for the initial severity 
of cognitive impairment, analyses were restricted 
to a sample comprising 31 UDem subjects and 126 
SDem subjects, all with an initial CDR of 1. In 
these analyses, a history of chronic pulmonary dis- 
ease (odds ratio [OR], 5.9; 95% confidence interval 
[CII, 1.6 to 21.71, three or more medications (OR, 
3.1; 95% CI, 1.3 to 7.91, and a history of chronic al- 
cohol intake (OR, 4.8; 95% CI, 1.0 to 22.1) were all 
independently predictive of UDem diagnosis. None 
of the other medical conditions or ethnicity, age, or 
education were significant predictors of dementia 
category, and they were excluded from the model. 
When we added the total recall from the Buschke 
Selective Reminding Test as a continuous variable 
to the previous model to adjust for the baseline 
severity of memory impairment, better perfor- 
mance was associated with increased likelihood of 
UDem (OR, 1.1; 95% CI, 1.0 to 1.21, but there was 
little change in the odds ratios associated with the 
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other significant predictors. The analyses were re- 
peated with the study population further restricted 
to UDem and SDem patients with the initial diag- 
nosis of PAD and a CDR of 1. Chronic pulmonary 
disease (OR, 13.8; 95% CI, 1.6 to 118.6) and a his- 
tory of taking more than three medications (OR, 
9.2; 95% CI, 1.5 to 58.5) were independently associ- 
ated with increased risk for unstable diagnosis, 
and a history of hypertension also conferred in- 
creased risk (OR, 8.0; 95% CI, 0.68 to 93.5), al- 
though this was not statistically significant. Once 
again, ethnicity, educational attainment, and age 
were not significant predictors and were excluded 
from the model. 
Discussion. About 90% of subjects diagnosed ini- 
tially as demented, or with probable AD specifi- 
cally, were again demented at 1-year follow-up. 
There were roughly one-half as many demented pa- 
tients whose diagnosis changed as there were pa- 
tients with IDem. A history of chronic pulmonary 
disease, taking three or more medications, and 
chronic alcohol use were all independently associ- 
ated with an increased likelihood that an initial di- 
agnosis of dementia would not be confirmed at fol- 
low-up. 
The neuropsychological paradigm and indepen- 
dent assessment of function that we employed pro- 
vide explicit operational criteria for a diagnosis of 
dementia. One consequence of defining a precise 
threshold for dementia diagnosis is that very small 
changes in neuropsychological performance may 
lead to diagnostic changes, and the biological 
meaning of these diagnostic changes may be com- 
plex. “Recovery“ from dementia should not be unex- 
pected.12J3 Improvement in cognitive performance 
over successive evaluations may even be seen in 
patients with probable AD. In two recent longitudi- 
nal studies of patients meeting NINCDS-ADRDA 
criteria for probable AD, six of 11014 and five of 54 
patients16 showed improved cognition at 12 or more 
months of follow-up. 
There are four settings in which a patient with 
an initial diagnosis of dementia might show appar- 
ent improvement on a subsequent evduat ion.  
First, patients with nonprogressive or slowly pro- 
gressive cognitive impairment whose neuropsycho- 
logical performance is at or near threshold for de- 
mentia diagnosis will be especially likely to change 
diagnostic category with repeat testing. In such 
subjects, minor variations in test score could read- 
ily swing them back across the diagnostic thresh- 
old. The results of our logistic analyses confirm the 
importance of proximity to threshold as a risk for 
this change in dementia diagnosis: demented sub- 
jects with better scores for :total recall”-ie, closer 
to cutoffs-were less likely to be demented at fol- 
low-up. Second, an intercurrent event (eg, small 
stroke, infection, etc) occurring just before the first 
assessment might lead to an  impression of im- 
provement, despite the presence of an underlying 
dementing process such as AD. Subsequent recov- 
ery from the effects of the preceding event might 
permit better performance at  follow-up than at  ini- 
tial examination. Several of the case vignettes out- 
lined above represent possible examples of such a 
mechanism. Third, marked variability of cognition 
over shorter time intervals might also lead to an 
apparent improvement in cognition in some pa- 
tients despite a declining trend, with first evalua- 
tions representing nadir performances and second 
evaluations representing peak performances. Such 
a mechanism might account for the association of 
chronic pulmonary disease and perhaps alcohol 
consumption with UDem, discussed further below. 
Finally, resolution or improvement of a reversible 
condition that was completely responsible for the 
initial dementia might account for the improve- 
ment in some subjects (ie, a true reversible demen- 
tia versus the mixed pathology invoked for the sec- 
ond mechanism). Within a population of individu- 
als including a majority with progressive dementia, 
biological factors causally linked with the four situ- 
ations outlined above but not associated with the 
dementia process itself might emerge as factors 
that predict dementia that is likely to vary. 
Chronic pulmonary disease was associated with 
an increased likelihood that the diagnosis of de- 
mentia would not be confirmed at follow-up. Neu- 
ropsychological abnormalities with a distinctive 
pattern of deficit@ occur in association with severe 
chronic obstructive pulmonary disease (COPD),17 
and such patients may improve after chronic oxy- 
gen administration.18 Of 200 consecutive patients 
with dementia, COPD was present as a treatable 
condition in 20; treatment recommendations were 
made in at  least five patients, but it is unclear to 
what extent these were associated with cognitive 
improvement. l3 Chronic obstructive lung disease 
may cause fluctuations in cognitive impairment re- 
flecting hypo~emiahypercapnia.~~ Our patient 4 re- 
quired home supplemental oxygen. 
A history of taking three or more prescription 
medications daily at baseline was also associated 
with diagnostic changes from dementia to cognitive 
impairment. Adverse drug reactions may con- 
tribute to the cognitive impairment due to dement- 
ing disorders such as AD, and cognition may im- 
prove with cessation of the responsible 
In our series, cognitive improvement was not due 
to a deliberate withdrawal of medications. Since 
compliance correlates inversely with the number of 
prescription  medication^,^^^^^ however, these sub- 
jects may have had a more variable intake com- 
pared with subjects whose diagnosis remained un- 
changed. 
A history of chronic alcohol use was also associ- 
ated with increased likelihood of diagnostic change. 
We did not have reliable quantitative data; how- 
ever, some subjects’ performances on neuropsycho- 
logical testing may have been affected by recent al- 
cohol consumption. 
Hypertension approached significance as a pre- 
dictor of diagnostic change among subjects with an 
initial diagnosis of probable AD. There are  re- 
p o r t ~ ~ ~ - ~ ~  of uncomplicated hypertension associated 
with cognitive decline, but the decline was less se- 
vere than among our patients whose diagnosis 
changed. 
Longitudinal epidemiologic studies of dementia 
typically require the participation of numerous 
clinicians who may vary in their application of di- 
agnostic criteria. Over the course of a long study, 
systematic drift in a clinician’s threshold for de- 
mentia diagnosis might occur, due for instance to 
an  increasing willingness to accept low educa- 
tional attainment as the sole explanation for poor 
performance on cognitive testing. We attempted 
to minimize the consequences of observer diag- 
nostic variability by specifying invariant neuro- 
psychological criteria for dementia. Low educa- 
tional attainment did not predict reversal of the 
diagnosis of dementia at follow-up, suggesting 
that our cutoffs were not inappropriately strin- 
gent: if the  cutoff lay within the  performance 
range of normal subjects with low educational at- 
tainment, we might have expected them to be 
overrepresented among the UDem group. On the 
other hand, because we did not adjust for educa- 
tional attainment in  the diagnostic process, we 
may have diagnosed individuals with less educa- 
tion earlier in the course of dementing diseases.28 
Cognitive impairment and dementia represent 
successive stages on a continuum of cognitive de- 
cline, and all our subjects with an initial diagno- 
sis of dementia that  changed had persisting cog- 
nitive impairment at the repeat evaluation. Pro- 
longed follow-up will clearly be important to de- 
termine which of those cognitively impaired sub- 
jects have progressive disease. 
There are some limitations to this study. Brain 
imaging was not obtained as a routine part of the 
subject evaluation. When CTs or MRIs were done, 
they were obtained by the subjects’ own personal 
physicians. Larson et a129 reviewed the value of CT 
in the diagnostic evaluation of patients with de- 
mentia and concluded that in the absence of a spe- 
cific clinical suspicion, CT findings rarely lead to a 
significant change in diagnosis. Nevertheless, the 
relative lack of laboratory input to the diagnostic 
process may have led to diagnostic errors in some 
cases. 
In  summary, we used a neuropsychological 
paradigm to diagnose dementia in a longitudinal 
study of community-dwelling elders at high risk for 
cognitive decline. Ethnicity and education did not 
affect the consistency of clinical diagnosis of de- 
mentia at 1-year follow-up, whereas a history of 
chronic pulmonary disease, multiple drug taking, 
or chronic alcohol use did-findings for which there 
are obvious or plausible explanations. A neuro- 
psychological paradigm such as ours may protect 
against inconsistency of dementia diagnosis related 
to interobserver variability or to systematic drift in 
the application of diagnostic criteria over the 
course of a prolonged study. 
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